Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bestrophin-4 is a member of the bestrophin family of calcium-activated chloride channels, encoded by the BEST4 gene, predominantly expressed in colon epithelial cells. It mediates the movement of chloride and bicarbonate ions in a calcium-dependent manner and helps regulate ion transport and epithelial cell function. Unlike other bestrophins, BEST4 has distinctive functional properties, including slow activation/deactivation kinetics and specific structural divergence in transmembrane and extra-membrane loop regions. Recent studies indicate BEST4 can suppress colorectal cancer cell proliferation, migration, and epithelial-mesenchymal transition (EMT) through upstream regulation by Hes4 and downregulation of Twist1, and its anti-tumor activity appears partly independent of its channel function. It is considered a molecular target for both ion transport modulation and clinical prognostication in colorectal cancer.
Inhibition of chloride channel activity (by DIDS, CaCCinh-A01); Activation of ion transport (by ionomycin, potential small-molecule agonists like PABA, glutamate, GABA)
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bestrophin-4 (BEST4).